Skip to main content

Advertisement

SpringerLink
Log in

Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease

  • Letter
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Greenfield S, Sheehe PR, Feldman HA (1971) Meningococcal carriage in a population of “(normal)” families. J Infect Dis 123:67–73

    Article  PubMed  CAS  Google Scholar 

  2. Janda WM, Knapp JS (2003) Neisseria and Moraxella catarrhalis. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology, 8th edn. ASM Press, Washington, DC, pp 585–608

    Google Scholar 

  3. Flexner S (1913) The results of the serum treatment in thirteen hundred cases of epidemic meningitis. J Exp Med 17:553–576

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Busani S, Damiani E, Cavazzuti I, Donati A, Girardis M (2016) Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness. Minerva Anestesiol 82:559–572

    PubMed  Google Scholar 

  5. Garbett ND, Munro CS, Cole PJ (1989) Opsonic activity of a new intravenous immunoglobulin preparation: pentaglobin compared with sandoglobulin. Clin Exp Immunol 76:8–12

    PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

GISA/SIMIT Meningitaly Study Group: Ferdinando Cellai—U.O. Rianimazione Lucca. Jessica Mencarini—Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Rosario Spina—UOC Anestesia e Rianimazione—Azienda Usl 11. Michele Trezzi—U.O. Malattie Infettive Pistoia, Pistoia, Italy. Spartaco Sani—U.O. Malattie Infettive Livorno. Paolo Roncucci—U.O. Anestesia e Rianimazione Livorno. Carolina Rescigno—First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Napoli, Italy. Pasquale Pagliano—First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Napoli, Italy. Vittorio Attanasio—First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Napoli, Italy. Raffaele Di Sarno—First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Napoli, Italy. Alessandro Viola—Intensive Care Unit, Cotugno Hospital, Azienda Ospedaliera dei Colli, Napoli, Italy. Cristiano Minucci—Intensive Care Unit, Cotugno Hospital, Azienda Ospedaliera dei Colli, Napoli, Italy. Italo Calamai—UOC Anestesia e Rianimazione - Azienda Usl 11. Simona Fortunato—Infectious Diseases Clinic, Nuovo Santa Chiara University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy. Enrico Tagliaferri—Infectious Diseases Clinic, Nuovo Santa Chiara University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy. Carlo Pallotto—First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Napoli, Italy; and Clinica delle Malattie infettive, Dipartimento di medicina, Università di Perugia, Perugia, Italy.

Disclosures

C. T. has received funds for speaking at symposia organized on behalf of Pfizer, Novartis, Merck and Astellas. M. F. received funds for speaking at symposia organized on behalf of Pfizer, Novartis, Merck, Astellas. All other authors: none to declare.

Author information

Authors and Affiliations

  1. First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Naples, Italy

    Carlo Tascini, Marco Rossi & Novella Carannante

  2. Intensive Care Unit, Cotugno Hospital, Azienda Ospedaliera dei Colli, Naples, Italy

    Fiorentino Fraganza & Maria Daniela Chiesa

  3. Infectious Diseases Clinic, Nuovo Santa Chiara University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

    Francesca Salani & Francesco Menichetti

  4. Emergency Medicine Unit, Nuovo Santa Chiara University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

    Emanuela Sozio

  5. Fondazione Toscana Gabriele Monasterio, Pisa, Italy

    Francesco Sbrana & Andrea Ripoli

  6. Pharmaceutical Department, Azienda Ospedaliera Universitaria Pisana, Santa Chiara, Pisa, Italy

    Giacomo Bertolino

  7. Infectious Diseases Unit, S. Maria Annunziata Hospital, Central Tuscany Health Authority, Florence, Italy

    Massimo Di Pietro

  8. Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy

    Alessandro Bartoloni

  9. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

    Alessandro Bartoloni

Authors
  1. Carlo Tascini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fiorentino Fraganza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Salani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emanuela Sozio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marco Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesco Sbrana
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Novella Carannante
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Maria Daniela Chiesa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Andrea Ripoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Giacomo Bertolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Massimo Di Pietro
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Alessandro Bartoloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Francesco Menichetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of GISA/SIMIT Meningitis Study Group

  • Ferdinando Cellai
  • , Jessica Mencarini
  • , Rosario Spina
  • , Michele Trezzi
  • , Spartaco Sani
  • , Paolo Roncucci
  • , Carolina Rescigno
  • , Pasquale Pagliano
  • , Vittorio Attanasio
  • , Raffaele Di Sarno
  • , Alessandro Viola
  • , Cristiano Minucci
  • , Italo Calamai
  • , Simona Fortunato
  • , Enrico Tagliaferri
  •  & Carlo Pallotto

Corresponding author

Correspondence to Francesco Menichetti.

Additional information

Collaborators of the GISA/SIMIT Meningitis Study Group are listed in “Acknowledgements” and in the ESM2.

GISA: Italian Group for Antimicrobial Stewardship; SIMIT: Italian Society for Infectious & Tropical Diseases.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 119 kb)

Supplementary material 2 (DOC 57 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tascini, C., Fraganza, F., Salani, F. et al. Potential role of IgM-enriched immunoglobulin as adjuvant treatment for invasive meningococcal disease. Intensive Care Med 44, 261–262 (2018). https://doi.org/10.1007/s00134-017-4957-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-017-4957-z

Search

Navigation